Current and future options for the diagnosis of malignant pleural effusion

Bibliography

• Roviaro GC, Varoli F, Rebuffat C, Videothoracoscopic staging and treatment of lung cancer. Ann Thorac Surg 1995;59:971-4
   PubMed Web of Science ®Google Scholar
• Loscertales J, Jimenez-Merchan R, Congregado M, Video-assisted surgery for lung cancer. State of the art and personal experience. Asian Cardiovasc Thorac Ann 2009;17:313-26
   PubMedGoogle Scholar
• Shim SS, Lee KS, Kim BT, Integrated PET/CT and the dry pleural dissemination of peripheral adenocarcinoma of the lung. Diagnostic implications. J Comput Assist Tomogr 2006;30:70-6
   PubMed Web of Science ®Google Scholar
• Peto J, Decarli A, La Vecchia C, The European mesothelioma epidemic. Br J Cancer 1999;79(3-4):666-72
   PubMed Web of Science ®Google Scholar
• Meyer PC. Metastatic carcinoma of the pleura. Thorax 1966;21:437-43
   PubMed Web of Science ®Google Scholar
• Rodriguez Panadero F, Borderas Naranjo F, Lopez Mejias J. Lymphatic mediastinal blockade as cause of pleural effusion. Med Clin (Barc) 1987;89:17:725-7
   PubMed Web of Science ®Google Scholar
• Light RW, Hamm H. Malignant pleural effusion: would the real cause please stand up? Eur Respir J 1997;10:1701-2
   PubMed Web of Science ®Google Scholar
• Sahn SA. Pleural diseases related to metastatic malignancies. Eur Respir J 1997;10:1907-13
   PubMed Web of Science ®Google Scholar
• Rodriguez Panadero F, Borderas Naranjo F, Lopez Mejias J. Benign pleural effusions in cancer patients. Frequency and etiopathogenic mechanism in a series of autopsy cases. Rev Clin Esp 1988;183:311-12
   PubMed Web of Science ®Google Scholar
• Froudarakis ME. Diagnostic work-up of pleural effusions. Respiration 2008;75(1):4-13
   PubMed Web of Science ®Google Scholar
• Lombardi G, Zustovich F, Nicoletto MO, Diagnosis and treatment of malignant pleural effusion: a systematic literature review and new approaches. Am J Clin Oncol 2010;33(4):420-3
   PubMed Web of Science ®Google Scholar
• Hooper C, Lee YC, Maskell N; BTS Pleural Guideline Group. Investigation of a unilateral pleural effusion in adults: british Thoracic Society Pleural Disease Guideline 2010. Thorax 2010;65(Suppl 2):ii4-17
   PubMed Web of Science ®Google Scholar
• Evans AL, Gleeson FV. Radiology in pleural disease: state of the art. Respirology 2004;9(3):300-12
   PubMed Web of Science ®Google Scholar
• Helm EJ, Matin TN, Gleeson FV. Imaging of the pleura. J Magn Reson Imaging 2010;32(6):1275-86
   PubMed Web of Science ®Google Scholar
• Gill RR. Imaging of mesothelioma. Recent Results Cancer Res 2011;189:27-43
   PubMedGoogle Scholar
• Qureshi NR, Rahman NM, Gleeson FV. Thoracic ultrasound in the diagnosis of malignant pleural effusion. Thorax 2009;64:139-43
   PubMed Web of Science ®Google Scholar
• Rahman NM, Singanayagam A, Davies HE, Diagnostic accuracy, safety and utilisation of respiratory physician-delivered thoracic ultrasound. Thorax 2010;65(5):449-53
   PubMed Web of Science ®Google Scholar
• Koegelenberg CF, von Groote-Bidlingmaier F, Bolliger CT. Transthoracic ultrasonography for the respiratory physician. Respiration 2012;84(4):337-50
   PubMed Web of Science ®Google Scholar
• Chira R, Chira A, Mircea PA. Thoracic wall ultrasonography - normal and pathological findings. Pictorial essay. Med Ultrason 2011;13(3):228-33
   PubMedGoogle Scholar
• Villena Garrido MV. Pleural ultrasound applications. Arch Bronconeumol 2012;48(8):265-6
   PubMed Web of Science ®Google Scholar
• Lichtenstein D, Hulot JS, Rabiller A, Feasibility and safety of ultrasound-aided thoracentesis in mechanically ventilated patients. Intensive Care Med 1999;25:955-8
   PubMed Web of Science ®Google Scholar
• Sartori S, Tombesi P, Tassinari D, Sonographically guided small-bore chest tubes and sonographic monitoring for rapid sclerotheraphy of recurrent malignant pleural effusions. J Ultrasound Med 2004;23:1171-6
   PubMed Web of Science ®Google Scholar
• Medford ARL. The utility of thoracic ultrasound before local anesthetic videoassisted thoracoscopy in patients with suspected pleural malignancy. J Clin Ultrasound 2010;38:222-5
   PubMed Web of Science ®Google Scholar
• Cassanelli N, Caroli G, Dolci G, Accuracy of transthoracic ultrasound for the detection of pleural adhesions. Eur J Cardiothorac Surg 2012;42(5):813-18
   PubMed Web of Science ®Google Scholar
• Biegler N, McBeth PB, Tevez-Molina MC, Just-in-time cost-effective off-the-shelf remote telementoring of paramedical personnel in bedside lung sonography. A technical case study. Telemed J E Health 2012;18(10):807-9
   PubMed Web of Science ®Google Scholar
• Zhou H, Tamura T, Kusaka Y, Development of a guideline on reading CT images of malignant pleural mesothelioma and selection of the reference CT films. Eur J Radiol 2012;81(12):4203-10
   PubMed Web of Science ®Google Scholar
• Maskell NA, Gleeson FV, Davies RJ. Standard pleural biopsy versus CT-guided cutting-needle biopsy for diagnosis of malignant disease in pleural effusions: a randomised controlled trial. Lancet 2003;361(9366):1326-30
   PubMed Web of Science ®Google Scholar
• Metintas M, Ak G, Dundar E, Medical thoracoscopy vs CT Scan-guided Abrams pleural needle biopsy for diagnosis of patients with pleural effusion. Chest 2010;137(6):1362-8
   PubMed Web of Science ®Google Scholar
• Hoppe H, Walder B, Sonnenschein M, Multidetector CT virtual bronchoscopy to grade tracheobronchial stenosis. AJR Am J Roentgenol 2002;178(5):1195-200
   PubMed Web of Science ®Google Scholar
• Sundarakumar DK, Bhalla AS, Sharma R, Multidetector CT evaluation of central airways stenoses: comparison of virtual bronchoscopy, minimal-intensity projection, and multiplanar reformatted images. Indian J Radiol Imaging 2011;21(3):191-4
   PubMedGoogle Scholar
• Carette MF, Chabchoub H, Tassart M, Virtual pleuroscopy of diaphragmatic pleura: myth or reality?. [Article in French]. Rev Pneumol Clin 2008;64(1):15-19
   PubMed Web of Science ®Google Scholar
• Morita Y, Takase K, Yamada T, Virtual CT thoracoscopy: preoperative simulation for thoracoscopic surgery of esophageal cancer. Abdom Imaging 2007;32(6):679-87
   PubMed Web of Science ®Google Scholar
• Yildirim D, Tamam M, Sanli Y, Virtual bronchoscopy using FDG-PET/CT images for the evaluation of lung cancer. Eur Rev Med Pharmacol Sci 2012;16(14):1951-60
   PubMed Web of Science ®Google Scholar
• Letovanec I, Allenbach G, Mihaescu A, 18F-fluorodeoxyglucose PET/CT findings in pleural effusions of patients with known cancer. A cytopathological correlation. Nuklearmedizin 2012;51(5):186-93
   PubMedGoogle Scholar
• Kim BS, Kim IJ, Kim SJ, Predictive value of F-18 FDG PET/CT for malignant pleural effusion in non-small cell lung cancer patients. Onkologie 2011;34(6):298-303
   PubMed Web of Science ®Google Scholar
• Alkhawaldeh K, Biersack HJ, Henke A, Ezziddin S. Impact of dual-time-point F-18 FDG PET/CT in the assessment of pleural effusion in patients with non-small-cell lung cancer. Clin Nucl Med 2011;36(6):423-8
   PubMed Web of Science ®Google Scholar
• Orki A, Akin O, Tasci AE, The role of positron emission tomography/computed tomography in the diagnosis of pleural diseases. Thorac Cardiovasc Surg 2009;57(4):217-21
   PubMed Web of Science ®Google Scholar
• Kwek BH, Aquino SL, Fischman AJ. Fluorodeoxyglucose positron emission tomography and CT after talc pleurodesis. Chest 2004;125(6):2356-60
   PubMed Web of Science ®Google Scholar
• Wilcox BE, Subramaniam RM, Peller PJ, Utility of integrated computed tomography-positron emission tomography for selection of operable malignant pleural mesothelioma. Clin Lung Cancer 2009;10(4):244-8
   PubMed Web of Science ®Google Scholar
• Razek AA. Diffusion magnetic resonance imaging of chest tumors. Cancer Imaging 2012;12:452-63
   PubMed Web of Science ®Google Scholar
• Gaertner FC, Furst S, Schwaiger M. PET/MR: a paradigm shift. Cancer Imaging 2013;13(1):3652
   Web of Science ®Google Scholar
• Antony VB, Loddenkemper R, Astoul P, Management of malignant pleural effusions. Eur Respir J 2001;18(2):402-19
   PubMed Web of Science ®Google Scholar
• Sahn SA. Getting the most from pleural fluid analysis. Respirology 2012;17:270-7
   PubMed Web of Science ®Google Scholar
• Moltyaner Y, Miletin MS, Grossman RF. Transudative pleural effusions. False reassurance against malignancy. Chest 2000;118:885
   PubMed Web of Science ®Google Scholar
• Fernandez C, Martin C, Aranda I, Romero S. Malignant transient pleural transudate: a sign of early lymphatic tumoral obstruction. Respiration 2000;67:333-6
   PubMed Web of Science ®Google Scholar
• Assi Z, Caruso JL, Herndon J, Patz EF Jr. Cytologically proved malignant pleural effusions. Distribution of transudates and exudates. Chest 1998;113:1302-4
   PubMed Web of Science ®Google Scholar
• Villena V, Lopez-Encuentra A, Garcia-Lujan R, Clinical implications of appearance of pleural fluid at thoracentesis. Chest 2004;125:156-9
   PubMed Web of Science ®Google Scholar
• Krenke R, Nasilowski J, Korczynski P, Incidence and aetiology of eosinophilic pleural effusion. Eur Respir J 2009;34:1111-17
   PubMed Web of Science ®Google Scholar
• Porcel JM, Esquerda A, Bielsa S. Diagnostic performance of adenosine deaminase activity in pleural fluid: a single-center experience with over 2100 consecutive patients. Eur J Intern Med 2010;21(5):419-23
   PubMed Web of Science ®Google Scholar
• Rodriguez-Panadero F. Medical thoracoscopy. Respiration 2008;76(4):363-72
   PubMed Web of Science ®Google Scholar
• Segal A, Sterrett GF, Frost FA, A diagnosis of malignant pleural mesothelioma can be made by effusion cytology: results of a 20 year audit. Pathology 2013;45(1):44-8
   PubMed Web of Science ®Google Scholar
• Porcel JM. Pearls and myths in pleural fluid analysis. Respirology 2011;16(1):44-52
   PubMed Web of Science ®Google Scholar
• Swiderek J, Morcos S, Donthireddy V, Prospective study to determine the volume of pleural fluid required to diagnose malignancy. Chest 2010;137(1):68-73
   PubMed Web of Science ®Google Scholar
• Metzgeroth G, Kuhn C, Schultheis B, Diagnostic accuracy of cytology and immunocytology in carcinomatous effusions. Cytopathology 2008;19:205-11
   PubMed Web of Science ®Google Scholar
• Su XY, Li GD, Liu WP, Cytological differential diagnosis among adenocarcinoma, epithelial mesothelioma, and reactive mesothelial cells in serous effusions by immunocytochemistry. Diagn Cytopathol 2011;39(12):900-8
   PubMed Web of Science ®Google Scholar
• Scherpereel A, Astoul P, Baas P, Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma. Eur Respir J 2010;35:479-95
   PubMed Web of Science ®Google Scholar
• Pomjanski N, Grote HJ, Doganay P, Immunocytochemical identification of carcinomas of unknown primary in serous effusions. Diagn Cytopathol 2005;33:309-15
   PubMed Web of Science ®Google Scholar
• Westfall DE, Fan X, Marchevsky AM. Evidence-based guidelines to optimize the selection of antibody panels in cytopathology: pleural effusions with malignant epithelioid cells. Diagn Cytopathol 2010;38(1):9-14
   PubMed Web of Science ®Google Scholar
• Tsai TH, Wu SG, Chang YL, Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma. J Thorac Oncol 2012;7(6):993-1000
   PubMed Web of Science ®Google Scholar
• Ninomiya K, Ohi S, Tabei I, Establishment and characterization of a cell line (BTIC) including HER-2-positive cells derived from pleural effusion of recurrent breast invasive ductal carcinoma, scirrhous type. Hum Cell 2007;20(3):85-90
   PubMed Web of Science ®Google Scholar
• Keklik M, Sivgin S, Pala C, Flow cytometry method as a diagnostic tool for pleural fluid involvement in a patient with multiple myeloma. Mediterr J Hematol Infect Dis 2012;4(1):e2012063
   PubMedGoogle Scholar
• Kentrou NA, Tsagarakis NJ, Tzanetou K, An improved flow cytometric assay for detection and discrimination between malignant cells and atypical mesothelial cells, in serous cavity effusions. Cytometry B Clin Cytom 2011;80(5):324-34
   PubMedGoogle Scholar
• Walts AE, Marchevsky AM. Low cost-effectiveness of CD3/CD20 immunostains for initial triage of lymphoid-rich effusions: an evidence-based review of the utility of these stains in selecting cases for full hematopathologic workup. Diagn Cytopathol 2012;40(7):565-9
   PubMed Web of Science ®Google Scholar
• Adusumilli PS, Gholami S, Chun YS, Fluorescence-assisted cytological testing (FACT): ex vivo viral method for enhancing detection of rare cancer cells in body fluids. Mol Med 2011;17(7-8):628-34
   PubMed Web of Science ®Google Scholar
• Krishan A, Ganjei-Azar P, Hamelik R, Flow immunocytochemistry of marker expression in cells from body cavity fluids. Cytometry A 2010;77(2):132-43
   PubMedGoogle Scholar
• Saliba AE, Saias L, Psychari E, Microfluidic sorting and multimodal typing of cancer cells in self-assembled magnetic arrays. Proc Natl Acad Sci USA 2010;107(33):14524-9
   PubMed Web of Science ®Google Scholar
• Mohanty SK, Dey P. Serous effusions: diagnosis of malignancy beyond cytomorphology. An analytic review. Postgrad Med J 2003;79(936):569-74
   PubMed Web of Science ®Google Scholar
• Froudarakis ME. Pleural effusion in lung cancer: more questions than answers. Respiration 2012;83(5):367-76
   PubMed Web of Science ®Google Scholar
• Stathopoulos GT. Translational advances in pleural malignancies. Respirology 2011;16(1):53-63
   PubMed Web of Science ®Google Scholar
• Han J, Cao S, Zhang K, Fluorescence in situ hybridization as adjunct to cytology improves the diagnosis and directs estimation of prognosis of malignant pleural effusions. J Cardiothorac Surg 2012;7:121
   PubMed Web of Science ®Google Scholar
• Flores-Staino C, Darai-Ramqvist E, Dobra K, Hjerpe A. Adaptation of a commercial fluorescent in situ hybridization test to the diagnosis of malignant cells in effusions. Lung Cancer 2010;68(1):39-43
   PubMed Web of Science ®Google Scholar
• Savic S, Franco N, Grilli B, Fluorescence in situ hybridization in the definitive diagnosis of malignant mesothelioma in effusion cytology. Chest 2010;138(1):137-44
   PubMed Web of Science ®Google Scholar
• Dikmen G, Dikmen E, Kara M, Diagnostic implications of telomerase activity in pleural effusions. Eur Respir J 2003;22(3):422-6
   PubMed Web of Science ®Google Scholar
• Maneechotesuwan K, Lertworawiwat A, Tscheikuna J, Wamanuttajinda V. Comparison of telomerase activity between malignant and tuberculous pleural effusions. J Med Assoc Thai 2006;89(Suppl 5):S46-54
   PubMedGoogle Scholar
• Hansson M, Zendehrokh N, Ohyashiki J, Telomerase activity in effusions: a comparison between telomere repeat amplification protocol in situ and conventional telomere repeat amplification protocol assay. Arch Pathol Lab Med 2008;132(12):1896-902
   PubMed Web of Science ®Google Scholar
• Shu J, Sun GY, Liu AP, Liu J. Diagnostic accuracy of human telomerase reverse transcriptase mRNA in malignant pleural effusions: a preliminary report for in situ hybridization detection. Clin Chim Acta 2007;381(2):131-5
   PubMed Web of Science ®Google Scholar
• Lee WY. Limitations of detection of malignancy in pleural effusions using ELISA-based TRAP assay: comparison with cytological examination. Cytopathology 2005;16(5):227-32
   PubMed Web of Science ®Google Scholar
• Zendehrokh N, Dejmek A. Telomere repeat amplification protocol (TRAP) in situ reveals telomerase activity in three cell types in effusions: malignant cells, proliferative mesothelial cells, and lymphocytes. Mod Pathol 2005;18(2):189-96
   PubMed Web of Science ®Google Scholar
• Shen YC, Chen ZN, Yang T, Telomerase activity assay for the diagnosis of malignant pleural effusion: a meta-analysis. Exp Ther Med 2012;4(3):487-92
   Web of Science ®Google Scholar
• Porcel JM, Vives M, Esquerda A, Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions. Chest 2004;126(6):1757-63
   PubMed Web of Science ®Google Scholar
• Gueugnon F, Leclercq S, Blanquart C, Identification of novel markers for the diagnosis of malignant pleural mesothelioma. Am J Pathol 2011;178:1033-42
   PubMed Web of Science ®Google Scholar
• Benjamin H, Lebanony D, Rosenwald S, A diagnostic assay based on microRNA expression accurately identifies malignant pleural mesothelioma. J Mol Diagn 2010;12:771-9
   PubMed Web of Science ®Google Scholar
• Ostroff RM, Mehan MR, Stewart A, Early detection of malignant pleural mesothelioma in asbestos-exposed individuals with a noninvasive proteomics-based surveillance tool. PLoS One 2012;7(10):e46091
   PubMed Web of Science ®Google Scholar
• Davies HE, Sadler RS, Bielsa S, Clinical impact and reliability of pleural fluid mesothelin in undiagnosed pleural effusions. Am J Respir Crit Care Med 2009;180(5):437-44
   PubMed Web of Science ®Google Scholar
• Hollevoet K, Reitsma JB, Creaney J, Serum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysis. J Clin Oncol 2012;30(13):1541-9
   PubMed Web of Science ®Google Scholar
• Creaney J, Francis RJ, Dick IM, Serum soluble mesothelin concentrations in malignant pleural mesothelioma: relationship to tumour volume, clinical stage and changes in tumour burden. Clin Cancer Res 2011;17:1181-9
   PubMed Web of Science ®Google Scholar
• Grigoriu BD, Chahine B, Vachani A, Kinetics of soluble mesothelin in patients with malignant pleural mesothelioma during treatment. Am J Respir Crit Care Med 2008;179:950-4
   Web of Science ®Google Scholar
• Kelly RJ, Sharon E, Pastan I, Hassan R. Mesothelin-targeted agents in clinical trials and in preclinical development. Mol Cancer Ther 2012;11(3):517-25
   PubMed Web of Science ®Google Scholar
• Macura SL, Hillegass JM, Steinbacher JL, A multifunctional mesothelin antibody-tagged microparticle targets human mesotheliomas. J Histochem Cytochem 2012;60(9):658-74
   PubMed Web of Science ®Google Scholar
• Pass HI, Levin SM, Harbut MR, Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma. N Engl J Med 2012;367(15):1417-27
   PubMed Web of Science ®Google Scholar
• Koegelenberg CF, Diacon AH. Pleural controversy: close needle pleural biopsy or thoracoscopy-which first? Respirology 2011;16(5):738-46
   PubMed Web of Science ®Google Scholar
• Escudero Bueno C, Garcia Clemente M, Cuesta Castro B, Cytologic and bacteriologic analysis of fluid and pleural biopsy specimens with Cope's needle. Study of 414 patients. Arch Inter Med 1990;150:1190-4
   PubMed Web of Science ®Google Scholar
• Canto A, Rivas J, Saumench J, Points to consider when choosing a biopsy method in cases of pleurisy of unknown origin. Chest 1983;84:176-9
   PubMed Web of Science ®Google Scholar
• Stigt JA, Boers JE, Groen HJ. Analysis of “dry” mesothelioma with ultrasound guided biopsies. Lung Cancer 2012;78(3):229-33
   PubMed Web of Science ®Google Scholar
• Rahman NM, Ali NJ, Brown G, Local anaesthetic thoracoscopy: british Thoracic Society Pleural Disease Guideline 2010. Thorax 2010;65(Suppl 2):ii54-60
   PubMed Web of Science ®Google Scholar
• Loddenkemper R. Thoracoscopy: state of the art. Eur Respir J 1998;11:213-21
   PubMed Web of Science ®Google Scholar
• Boutin C, Viallat JR, Cargnino P, Farisse P. Thoracoscopy in malignant pleural effusions. Am Rev Respir Dis 1981;124:588-92
   PubMed Web of Science ®Google Scholar
• Villena V, Lopez Encuentra A, De Pablo A, Ambulatory diagnosis of the patients requiring a pleural biopsy. Study of 100 consecutive cases. Arch Bronconeumol 1997;33(8):395-8
   PubMedGoogle Scholar
• Naito T, Satoh H, Ishikawa H, Pleural effusion as a significant prognostic factor in non-small cell lung cancer. Anticancer Res 1997;17:4743-6
   PubMed Web of Science ®Google Scholar
• See KC, Lee P. Advances in the diagnosis of pleural disease in lung cancer. Ther Adv Respir Dis 2011;5(6):409-18
   PubMedGoogle Scholar
• Martin Diaz E, Arnau Obrer A, Martorell Cebollada M, Canto Armengod A. La toracocentesis en la evaluacion del cancer de pulmon con derrame pleural. Thoracocentesis for the assessment of lung cancer with pleural effusion. Arch Bronconeumol 2002;38:479-84
   PubMedGoogle Scholar
• Rodriguez-Panadero F. Lung cancer and ipsilateral pleural effusion. Ann Oncol 1995;6(Suppl 3):S25-7
   PubMedGoogle Scholar
• Roberts JR, Blum MG, Arildsen R, Prospective comparison of radiologic, thoracoscopic, and pathologic staging in patients with early non-small cell lung cancer. Ann Thorac Surg 1999;68:1154-8
   PubMed Web of Science ®Google Scholar
• Sawabata N, Matsumura A, Motohiro A, Malignant minor pleural effusion detected on thoracotomy for patients with non-small cell lung cancer: is tumor resection beneficial for prognosis? Ann Thorac Surg 2002;73:412-15
   PubMed Web of Science ®Google Scholar
• Lee P, Hsu A, Lo C, Colt HG. Prospective evaluation of flex-rigid pleuroscopy for indeterminate pleural effusion: accuracy, safety and outcome. Respirology 2007;12(6):881-6
   PubMed Web of Science ®Google Scholar
• Mohan A, Chandra S, Agarwal D, Utility of semirigid thoracoscopy in the diagnosis of pleural effusions: a systematic review. J Broncholy Interv Pulmonol 2010;17(3):195-201
   Google Scholar
• Wrightson JM, Davies HE. Outcome of patients with nonspecific pleuritis at thoracoscopy. Curr Opin Pulm Med 2011;17(4):242-6
   PubMed Web of Science ®Google Scholar
• Servais EL, Suzuki K, Colovos C, An in vivo platform for tumor biomarker assessment. PLoS One 2011;6(10):e26722
   PubMed Web of Science ®Google Scholar
• Chrysanthidis MG, Janssen JP. Autofluorescence videothoracoscopy in exudative pleural effusions: preliminary results. Eur Respir J 2005;26(6):989-92
   PubMed Web of Science ®Google Scholar
• Schonfeld N, Schwarz C, Kollmeier J, Narrow band imaging (NBI) during medical thoracoscopy: first impressions. J Occup Med Toxicol 2009;4:24
   PubMedGoogle Scholar
• Ishida A, Ishikawa F, Nakamura M, Narrow band imaging applied to pleuroscopy for the assessment of vascular patterns of the pleura. Respiration 2009;78(4):432-9
   PubMed Web of Science ®Google Scholar
• Pikin O, Filonenko E, Mironenko D, Fluorescence thoracoscopy in the detection of pleural malignancy. Eur J Cardiothorac Surg 2012;41(3):649-52
   PubMed Web of Science ®Google Scholar
• Adusumilli PS, Eisenberg DP, Stiles BM, Virally-directed Fluorescent Imaging (VFI) can Facilitate Endoscopic Staging. Surg Endosc 2006;20(4):628-35
   PubMed Web of Science ®Google Scholar
• Baas P, Triesscheijn M, Burgers S, Fluorescence detection of pleural malignancies using 5-aminolaevulinic acid. Chest 2006;129(3):718-24
   PubMed Web of Science ®Google Scholar
• Vandermeulen L, Makris D, Mordon S, Thoracoscopic findings and pharmacokinetics of inhaled fluorescein in a pig model. Respiration 2010;80(3):228-35
   PubMed Web of Science ®Google Scholar
• Maskell NA. New directions in thoracoscopy: is the future fluorescent? Respiration 2010;80(3):188-9
   PubMed Web of Science ®Google Scholar
• Ashitate Y, Tanaka E, Stockdale A, Near-infrared fluorescence imaging of thoracic duct anatomy and function in open surgery and video-assisted thoracic surgery. J Thorac Cardiovasc Surg 2011;142(1):31-8; e1-2
   PubMed Web of Science ®Google Scholar
• Lee P, Mathur PN, Colt HG. Advances in thoracoscopy: 100 years since Jacobaeus. Respiration 2010;79(3):177-86
   PubMed Web of Science ®Google Scholar
• Froudarakis ME. New challenges in medical thoracoscopy. Respiration 2011;82(2):197-200
   PubMed Web of Science ®Google Scholar
• Servais EL, Colovos C, Kachala SS, Adusumilli PS. Pre-clinical mouse models of primary and metastatic pleural cancers of the lung and breast and the use of bioluminescent imaging to monitor pleural tumor burden. Curr Protoc Pharmacol 2011; Chapter 14:Unit14.21; doi: 10.1002/0471141755. ph1421s54
   PubMedGoogle Scholar
• Stathopoulos GT, Kalomenidis I. Malignant pleural effusion: tumor-host interactions unleashed. Am J Respir Crit Care Med 2012;186(6):487-92
   PubMed Web of Science ®Google Scholar
• Stathopoulos GT, Kalomenidis I. Animal models of malignant pleural effusion. Curr Opin Pulm Med 2009;15(4):343-52
   PubMed Web of Science ®Google Scholar
• Kim KU, Wilson SM, Abayasiriwardana KS, A novel in vitro model of human mesothelioma for studying tumor biology and apoptotic resistance. Am J Respir Cell Mol Biol 2005;33(6):541-8
   PubMed Web of Science ®Google Scholar
• Mancini R, Giarnieri E, De Vitis C, Spheres derived from lung adenocarcinoma pleural effusions: molecular characterization and tumor engraftment. PLoS One 2011;6(7):e21320
   PubMed Web of Science ®Google Scholar
• Phung YT, Barbone D, Broaddus VC, Ho M. Rapid generation of in vitro multicellular spheroids for the study of monoclonal antibody therapy. J Cancer 2011;2:507-14
   PubMed Web of Science ®Google Scholar
• Xiang X, Phung Y, Feng M, The development and characterization of a human mesothelioma in vitro 3D model to investigate immunotoxin therapy. PLoS One 2011;6(1):e14640
   PubMed Web of Science ®Google Scholar
• Mahmood U, Weissleder R. Near-infrared optical imaging of proteases in cancer. Mol Cancer Ther 2003;2:489-96
   PubMed Web of Science ®Google Scholar
• Yan X, Zhou Y, Liu S. Optical imaging of tumors with copper-labeled rhodamine derivatives by targeting mitochondria. Theranostics 2012;2(10):988-98
   Google Scholar
• Backer MV, Backer JM. Imaging key biomarkers of tumor angiogenesis. Theranostics 2012;2(5):502-15
   PubMed Web of Science ®Google Scholar
• Alberti C. From molecular imaging in preclinical/clinical oncology to theranostic applications in targeted tumor therapy. Eur Rev Med Pharmacol Sci 2012;16(14):1925-33
   PubMed Web of Science ®Google Scholar
• Zhang H, Tian M, Li E, Molecular imaging-guided theranostics and personalized medicine. J Biomed Biotechnol 2012;2012:747416
   PubMedGoogle Scholar
• Josefsen LB, Boyle RW. Unique diagnostic and therapeutic roles of porphyrins and phthalocyanines in photodynamic therapy, imaging and theranostics. Theranostics 2012;2(9):916-66
   PubMed Web of Science ®Google Scholar
• Massoud TF, Gambhir SS. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 2003;17:545-80
   PubMed Web of Science ®Google Scholar
• Cheng Z, Levi J, Xiong Z, Near-infrared fluorescent deoxyglucose analogue for tumor optical imaging in cell culture and living mice. Bioconj Chem 2006;17:662-9
   PubMed Web of Science ®Google Scholar
• Hama Y, Urano Y, Koyama Y, A target cell-specific activatable fluorescence probe for in vivo molecular imaging of cancer based on a self-quenched Avidin-Rhodamine conjugate. Cancer Res 2007;67:2791-9
   PubMed Web of Science ®Google Scholar
• Longmire MR, Ogawa M, Hama Y, Determination of optimal rhodamine fluorophore for in vivo optical imaging. Bioconj Chem 2008;19:1735-42
   PubMed Web of Science ®Google Scholar
• Ntziachristos V, Bremer C, Weissleder R. Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging. Eur Radiol 2003;13:195-208
   PubMed Web of Science ®Google Scholar
• Rabbani H, Javanmard SH. Image analysis in in vivo stem cell tracking. Ann Rev Res Biol 2011;1(4):123-42
   Google Scholar
• Morawski AM, Winter PM, Crowder KC, Targeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRI. Magn Reson Med 2004;51(3):480-6
   PubMed Web of Science ®Google Scholar
• Koole R, van Schooneveld MM, Hilhorst J. Paramagnetic lipid-coated silica nanoparticles with a fluorescent quantum dot core: a new contrast agent platform for multimodality imaging. Bioconjug Chem 2008;19(12):2471-9
   PubMed Web of Science ®Google Scholar
• Hirsch LR, Stafford RJ, Bankson JA. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci USA 2003;100(23):13549-54
   PubMed Web of Science ®Google Scholar